NEW YORK (Reuters Health) – The combination of niacin and fenofibrate, along with diet and exercise, markedly improves the lipid profile of HIV patients on antiretroviral therapy (ART),…
NEW YORK (Reuters Health) – Even when small, nonfunctioning pancreatic endocrine tumors are likely to be aggressive, and should be removed when they are discovered incidentally, according to…
NEW YORK (Reuters Health) – For patients with type 2 diabetes not controlled with metformin and a sulfonylurea, the choice of an additional agent should be based on…
NEW YORK (Reuters Health) – Cotreatment with an angiotensin-converting enzyme (ACE) inhibitor reduces the risk of diabetes associated with beta blocker treatment, according to a report in the…
NEW YORK (Reuters Health) – For women with anorexia nervosa, weekly risedronate increases spinal bone mineral density over the course of a year. Adding low-dose testosterone does not…
NEW YORK (Reuters Health) – For children and adolescents with conditions that require frequent placement of intravenous lines, administration of 50% nitrous oxide makes the process of IV…
NEW YORK – Hemoglobin A1c (A1C) levels are not sensitive or specific enough to be used to identify children and adolescents with or at risk for diabetes, according…
NEW YORK (Reuters Health) – Insulin resistance substantially curbs the chances of a sustained viral response following standard treatment for chronic hepatitis C virus (HCV) infection, according to…
NEW YORK (Reuters Health) – The risk of pancreatic malignancy is increased in patients with diabetes, researchers from Taiwan report in a pre-print version of a study that…
NEW YORK (Reuters Health) – An updated review of medications available for treating type 2 diabetes concludes that metformin continues to have the best benefit-to-harm profile, according to…